Syngene International Ltd SHARE PRICE [LIVE]

BSE: 539268
To view real time prices Login to your account
Already an existing customer? - Login Now!
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
Div yield:

Fundamental analysis


0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Outperformed Sector by 9.87% and Underperformed Sensex by -5.45%
MARKET CAP (Large Cap Stock)Rs 22,787 Cr
PE (TTM) 52.17
PE Ratio52.73
Price to Book Value6.98
EV to EBIT43.82
EV to EBITDA26.14
EV to Capital Employed7.16
EV to Sales7.70
PEG Ratio7.50
Dividend Yield0.18%
ROCE (Latest)15.98%
ROE (Latest)13.06%
NameDec 22Sep 22
Promoters (Change:0.00) 64.86%64.86%
FIIs (Change:0.09) 16.86%16.77%
Mutual Funds (Change:0.23) 5.01%4.78%
Insurance Companies (Change:0.15) 0.32%0.17%
Other DIIs (Change:-0.12) 1.71%1.83%
Non Institution (Change:-0.34) 11.24%11.58%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Syngene International Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %


Frequently Asked Questions

What is the Share price of Syngene International Ltd (SYNGENE)?

Syngene International Ltd (SYNGENE) share price as of February 4, 2023, on NSE is Rs 566.70 (NSE) and Rs 569.30 (BSE) on BSE.

Can I buy Syngene International Ltd (SYNGENE) shares?

Yes, You can buy Syngene International Ltd (SYNGENE) shares by opening a Demat account with Angel One.

How do I buy Syngene International Ltd (SYNGENE) from Angel One?

Syngene International Ltd (SYNGENE) share can be brought through the following modes:
  1. Direct investment: You can buy Syngene International Ltd (SYNGENE) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Syngene International Ltd (SYNGENE) shares.

In which sector do Syngene International Ltd (SYNGENE) belong?

Syngene International Ltd (SYNGENE) belongs to Pharma.

Is Syngene International a Debt free Company?

No, Syngene International is not a debt free company.

What is the main business of Syngene International?

The main business of Syngene International is to research, develop, and provide scientific molecules and solutions across varied industries, such as pharmaceuticals, animal health, biotechnology, consumer goods, nutrition, and specialty chemical companies.

Who are the promoters of Syngene International?

Some of the main promoters of Syngene International are Biocon Limited, Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha), Kiran Mazumdar Shaw, Biocon Research Limited, Ravi Rasendra Mazumdar, and Dev Mazumdar.

What are the Subsidiaries that comes under Syngene International?

The only wholly-owned subsidiary that comes under Syngene International is Syngene USA Inc.


Today's live share price for Syngene International Ltd is NSE: ₹ 566.70, BSE: ₹ 569.30 with a current market capitalization of .

Syngene International Limited is an internationally reputed contract research and manufacturing organisation with multidisciplinary skills in chemistry and biology services. The company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited. The company was formed with objectives of providing contract research service to overseas customer in the field of synthetic chemistry, molecular biology and custom synthesis. The company was incorporated at Bangalore in the year 1993. During the year 1994-1995, the company pioneered in CRO services for both Chemistry and Biology. During the year 2001-2002, the company acquired a new facility inclusive of a cGMP pilot plant. In March 30, 2002, the company`s 99.9% equity share was transferred to Biocon and the company became a subsidiary of Biocon Ltd. During the year 2003-2004, the company introduced Process Research and Optimization Services. In October 21, 2004, the company commissioned a new research facility at Boammasandra, Bangalore. In February 15, 2006, the company commissioned new facility at Biocon Park. In August 30, 2006, the company received approval of additional facility to set up as SEZ unit from Cochin Special Economic Zone. During the year 2006-2007, Bristol- Myers Squibb had entered into a long term agreement with the company to set up an exclusive research facility to house more than 400 scientists. During the year, the company had ventured into other area of Biology viz Genetic Engineering, Protein Chemistry, and assay development. The company had developed extensive expertise in the creation of customized stable cell lines expressing proteins / receptors of intersest. During the year 2007-2008, the company entered a long term service agreement with BMS. During the year 2008-2009, the company created an alliance partnership with DuPont Crop Protection.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers